NORCROSS, Ga., March 31, 2015 /PRNewswire/ -- Fastin Rapid Release® is a quantum leap in the field of weight loss backed by two clinical studies -- one showed an increase in the metabolism by 22% in 45 minutes*, and the second study showed Fastin Rapid Release® users lost 208% more weight and 385% more fat than placebo**. The results seen with Fastin Rapid Release® were compared by Hi-Tech Researchers to previous studies on Ephedrine -- the Gold Standard for OTC diet aids. The findings were amazing as Fastin Rapid Release® was found to be 66% stronger than 30mg Ephedrine and 152% stronger than 10mg Ephedrine.
Fastin Rapid Release® has a multi-million dollar advertising campaign that has been launched as it was initially sold exclusively at the Nationwide Retailer Rite Aid. Hi-Tech distributors have now begun to take on the product and other major chains are in the process of placing orders. Fastin Rapid Release® is a state-of the-art weight loss aid manufactured by Hi-Tech Pharmaceuticals - where science never stands still!
Fastin Rapid Release® is a new weight and fat loss product from Hi-Tech Pharmaceuticals, Inc. (“Hi-Tech”) that is unlike any diet & energy aid to ever be released on the supplement market! Fastin Rapid Release® is made with Explotab® technology for an immediate burst of the active ingredients, providing rapid onset of explosive energy and thermogenesis. Fastin Rapid Release® incorporates an advanced delivery system to put the ingredient powerhouse into action. Hi-Tech chose to use Explotab®, which is remarkably effective for rapid disintegration and enhanced dissolution. The mechanism by which this action takes place involves accelerated absorption of water leading to an enormous increase in the volume of granules. This results in rapid and uniform tablet disintegration leading to increases in the metabolism by 22% in 45 minutes; study analyses revealed no significant differences between conditions at baseline in values of VO2, VE, or RER. Results indicated that VO2 change scores for FAS were significantly greater at all time points following ingestion (+22.1%, +18.9%, +15.9%, +12.6%, +8.4%) compared with PL (0.4%, -1.7%, -2.3%, -1.1%, 0.5%) and compared with CAF ( +6.3%, +6.5%, +7.1%, +4.2 %, +3.6%) (p’s < 0.05). Similar response patterns were observed for VE as VO2 with FAS: (+26.6, +22.9%, +23.3%, +18.7%, +9.0%), CAF (+6.3%, +9.4%, +7.8%, +7.6%, +9.3%) and PL (-1.3%, -2.5%, -1.9%, -3.6%, +3.1%). The FAS VE change scores were significantly greater than CAF and PL at 45 min, 90min and 3 hrs (p<0.05). The RER change scores with PL and CAF were within 2% of baseline values across the six hours of testing. In contrast, FAS produced a pattern of declining values of RER over time to 9% and 11% below baseline at 4½ hrs and 6 hrs post ingestion, respectively, which were significantly less than CAF and PL.
“The nationwide launch of Fastin Rapid Release® is an important development for men and women who struggle with being overweight with and need help with weight management beyond diet and exercise,” said Jared Wheat, Hi-Tech’s President and Chief Executive Officer. “We thank our entire team and the people who participated in our clinical trial programs for making this achievement possible.” Hi-Tech expects to sell a lot of Fastin Rapid Release® considering that more than a third of U.S. adults, 78.6 million, are overweight, according the federal Centers for Disease Control and Prevention.
“The ideal candidate for a diet pill is to help people who are overweight is someone who uses the Fastin Rapid Release® as a tool, along with diet and exercise,” says Wheat.
Hi-Tech will manufacture and supply the finished commercial product from its FDA Registered Drug facility in Pennsylvania. Very few dietary supplement companies have a facility that is a FDA-Registered facility for Pharmaceuticals. Hi-Tech has (5) US based facilities totaling over 400,000 square feet, which is among the largest in our industry.
Fastin Rapid Release® is a revolutionary stimulant, fat loss aid, and helps people lose weight and feel great, as shown in the change in mean total body weight of the Fastin-RR group (-8.0 +/= 6.5 lbs) was significantly greater than the change in body weight observed in the Placebo group (-2.6 +/= 4.8) and in the Caffeine group (-3.0 +/= 5.5) (p’s < 0.05), and in The decrease in body fat weight observed in the Fastin-RR group (-6.3 +/= 7.3 lbs) was statistically greater than the body fat weight loss in the Placebo group (-1.3 +/= 6.7 lbs) (p < 0.05). Fastin Rapid Release® works by mimicking the effects of our endogenous catecholamines such as epinephrine, norepinephrine and dopamine. The principal mechanism of its action relies on its indirect stimulation of the adrenergic receptor system, which is part of the sympathetic nervous system (SNS), by increasing the activity of noradrenaline at the post-synaptic alpha- and beta-receptors. Fastin Rapid Release® has indirect sympathomimetic effects and due to its ability to cross the blood brain barrier, it is a CNS stimulant similar to ephedrine and other stimulants as it releases noradrenaline and dopamine. This helps you feel like doing more activities resulting in additional weight being lost due to exercise combined with Fastin Rapid Release®.
Fastin Rapid Release® users saw an Incredible 16.6 % increase in Resting Energy Expenditure (Metabolism) over the first 3 hours with an increase of over 14.5% in Energy Uptake over the entire 6+ hours! These findings also indicate that Fastin Rapid Release® produced a substantial shift in energy substrate utilization with significantly greater levels of fat oxidation.
According to Jared Wheat, “Fastin Rapid Release® really is the pre-eminent diet aid on the market right now because unlike most of the weight loss supplements on the market, it actually has two product-specific studies that provide evidence of efficacy. One study was conducted on Fastin Rapid Release® and its effects on the metabolic rate***. The second study was an 8 week weight loss and fat loss study that showed it caused people to lose 208% more weight and 385% more fat than placebo! It is a product dieters can trust to help them achieve their weight loss goals.”
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to treat, cure, diagnose, or prevent any disease. This product should not be used in place of or as a substitute for recommendations by your healthcare professional. WARNING: this product can raise blood pressure and interfere with other drugs you may be taking. Talk to your doctor about this product.
About Hi-Tech:
Hi-Tech Pharmaceuticals, Inc. is a leading global healthcare supplier that develops, manufactures and distributes dietary supplements, over-the-counter (OTC) and prescription pharmaceuticals, beverages, bulk dietary raw materials, and consumer products. Hi-Tech Pharmaceuticals is an enormously successful company that creates, manufactures and sells high-quality herbal products sold by the large, major retailers across the United States. These retailers include: GNC, Rite Aid, Vitamin Shoppe, NBTY, Kroger, Albertson’s, CVS, Kmart, Hannaford, Cardinal Health, Mckesson Corporation, AmerisourceBergen, Harmon Stores, Fred Meyer, Osco Drugs, Supervalu, Roundy’s, Sav-On Drugs, Meijer, Fruth Pharmacy, Kinney Drug, Kinray, A&P, Stop & Shop, Giant Eagle, HEB, Winn Dixie, Ingles, Food Lion, Harris Teeter, Bed Bath & Beyond, Amazon.com, and over 5,000 health food retailers and adult novelty stores, as well as in more than 80,000 convenience stores throughout the United States. Hi-Tech owns the brand names Hi-Tech Pharmaceuticals, Advanced Performance Supplements (APS), Nature’s Essentials, and ALR Industries.
Hi-Tech Pharmaceuticals and its CEO Jared Wheat’s Acquisition of Nittany Pharmaceuticals in late 2012 immediately doubled our solid dose and powder square footage. The former Nittany facility is a 130,000 sq. ft. modern facility located in central Pennsylvania, nestled in the scenic Big Valley 30 miles east of State College and 60 miles northwest of Harrisburg, Nittany was a full-service contract manufacturer that enjoyed continuous growth over the past 26 years in the nutrition and pharmaceutical industry. The 130,000 sq. ft. State-of-the art FDA registered facility follows strict Good Manufacturing Practices (cGMP). This facility also has a 10,000 sq. ft. science center which includes new state-of-the-art formulation development and QC laboratories along with a pilot scale manufacturing operation. The name was changed for that facility to Hi-Tech Nutraceuticals, LLC.
Hi-Tech is one of the world’s leading generics and branded pharmaceutical companies, providing products to customers throughout the world. The company maintains one of the industry’s broadest and highest quality product portfolios, which is regularly bolstered by an innovative and robust product pipeline. Hi-Tech has attained leading positions in key international markets through its wide array of dosage forms and delivery systems, significant manufacturing capacity, global commercial scale and a committed focus on quality and customer service. The company ranks among the top dietary supplement companies in several markets around the world and has among the largest capacity of dietary supplements or generic drugs of any U.S.-based manufacturers.
CONTACT: Brandon Schopp, 888-855-7919
*** http://www.jissn.com/content/10/S1/P11
Logo - http://photos.prnewswire.com/prnh/20150331/195758LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hi-tech-pharmaceuticals-announces-fastin-rapid-release-clinical-study-results-300058770.html
SOURCE Hi-Tech Pharmaceuticals, Inc.
Help employers find you! Check out all the jobs and post your resume.